
---
title: '上证科创板生物医药指数即将发布'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=790'
author: 证券时报网
comments: false
date: Tue, 12 Apr 2022 22:13:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=790'
---

<div>   
<p>证券时报e公司讯，今日，上海证券交易所和中证指数有限公司正式宣布了上证科创板生物医药指数（简称科创生物指数）发布的相关安排。经流动性筛选后，科创生物指数选取50只市值较大的生物医药、生物医学工程、其他生物业等领域公司证券作为指数样本，前5大权重股分别为<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688180" style="color: #2f67d1;text-decoration: none;" code="688180" target="_blank">君实生物</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688298" style="color: #2f67d1;text-decoration: none;" code="688298" target="_blank">东方生物</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688185" style="color: #2f67d1;text-decoration: none;" code="688185" target="_blank">康希诺</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688202" style="color: #2f67d1;text-decoration: none;" code="688202" target="_blank">美迪西</a>和<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688139" style="color: #2f67d1;text-decoration: none;" code="688139" target="_blank">海尔生物</a>，合计权重为33%。</p>

                  
</div>
            